The Numbers Don't Lie: Monsanto Ahead of Earnings

The video discusses Bayer's acquisition of Monsanto, highlighting the need for antitrust approval in 30 jurisdictions. The deal would create the largest producer of pesticides and genetically modified seeds. Market conditions have led to consolidation in crop chemicals, and investors are skeptical, with Monsanto's stock below Bayer's offer. Financial performance shows weakness in Bayer's AG Division, and there's concern about Bayer's shift from pharma. Monsanto forecasts earnings growth in 2017, driven by Intacta and Roundup sales.

What are the concerns regarding the antitrust approval for the Bayer and Monsanto deal?

How would the acquisition of Monsanto by Bayer affect the agricultural market?

What impact have low crop prices had on Monsanto's customers?

What are the expected contributions of Monsanto to Bayer's business after the acquisition?

What are the forecasts for Monsanto's earnings growth in fiscal 2017?